December 2016
 
Table of Contents
 


Funding Opportunities


Advanced Development and Validation of Merging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)

 

Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)

 

 

 

View a full list of current funding opportunities. 




Open
Recruitments
Highlighted positions related to cancer for which VCU is currently hiring. View the full list.

 

Chair, Division of Epidemiology (F52780)

 

Sr. Physician Scientist - Director Cancer Immunotherapy Program (F16770)


Shared Resource Spotlight
Transgenic/Knockout Mouse Core

Located on the eighth floor of the Molecular Medicine Research Building, the Transgenic/Knockout Mouse facility offers services to Massey researchers related to transgenic mouse production, embryo cryopreservation, breeding colony management, tail DNA genotyping and much more. The laboratory is equipped with an expansive selection of advanced technology including an Olympus IX-71 inverted injection scope with stage cooler, two Eppendorf TransferMan 4r micromanipulators, an Eppendorf Femtojet 4i microinjector, an Olympus DP-72 Digital Camera, a Vibroplane air table, a Bio-Cool III controlled rate freezer, two VWR CryoPro LN2 holding tanks, among others.

 

For more information, please contact resource director

Jolene Windle, Ph.D., or resource manager Greg Campbell, or visit the Massey website.


Leaders' Update Update 
 
A message from Vanessa Sheppard, associate director for disparities research

I am thrilled and honored to join Massey Cancer Center and to serve as its first associate director for disparities research.

 

This message continues with more about: 

-The new role of associate director for disparities research at Massey

-Massey's current contributions in disparities research and plans for advancing this work

-Opportunities for researchers to collaborate in activities aimed at alleviating cancer disparities

 

 

Research HighlightsHighlights
New combination of chemotherapy and immunotherapy combats breast cancer cell recurrence
 
Dr. Manjili in lab
Masoud Manjili, D.V.M., Ph.D.,
Cancer Cell Signaling 
member
In pre-clinical experiments, Massey researchers have reported promising results toward the eradication of breast cancer recurrence through a combination of Adriamycin, a standard chemotherapeutic agent, and a form of immunotherapy. Led by Masoud Manjili, the study, published in the Journal of Leukocyte Biology, demonstrated that a chemo-immunotherapeutic protocol overcame tumor-induced suppression, heightened tumor cells' vulnerability to immunotherapy and extended survival in animal models of metastatic breast cancer.

 

 

Tumor cell target discovered that can be inhibited to develop novel immunotherapy
 
Joseph Landry, Ph.D.
Cancer Molecular Genetics member
Research conducted by Joseph Landry and a team of Massey scientists found that the chromatin-remodeling complex known as nucleosome remodeling factor (NURF) regulates gene expression in tumors. Published in Cancer Research, Landry's team used mouse models with strong immune systems to determine that tumor growth slowed, and sometimes completely retreated, when cancer cells were depleted of NURF, and that T-cells more actively killed NURF-depleted tumor cells.

 

 

Center News Center1
New Pancreas Program to improve pancreatic cancer treatment outcomes

Massey's new Pancreas Program at Stony Point allows patients to see a variety of specialists on the same day at one location. This multidisciplinary and patient-centered approached, led by program director Dr. Brian Kaplan, is designed to improve pancreatic cancer treatment outcomes while 
reducing  wait times and anxiety.


Member Showcase MemberShowcase

Sheppard is an expert in reducing inequities in cancer outcomes


Vanessa Sheppard, Ph.D.  Cancer Prevention and Control co-leader
Vanessa Sheppard was named as Massey's associate director for disparities research and will also serve as co-leader of the Cancer Prevention and Control (CPC) research program. In these roles, she will lead Massey's efforts to advance high-priority disparities and minority health research across its various research programs and themes. Sheppard is chair of and professor in the Department of Health Behavior and Policy at the VCU School of Medicine.



Researcher Recognition Recognition
Two Massey genetic counselors appointed to state advisory board

Heather Creswick, M.S., C.G.C., and John Quillin, Ph.D., C.G.C. 
Governor Terry McAuliffe recently announced the appointment of Heather Creswick and John Quillin, both genetic counselors at Massey's Familial Cancer Clinic, to Virginia's Advisory Board on Genetic Counseling (AB). The AB develops regulations that will guide the implementation of genetic counseling licensure legislation and aid with legal processes of licensed genetic counselors. Quillin is a member of Massey's Cancer Prevention and Control research program and Creswick is an instructor in the Department of Human and Molecular Genetics at the VCU School of Medicine.





For a full listing of events, 

mediaMassey in the Media
 

NewsTop Cancer News
  
American Cancer Society
Share with us your research, awards and accomplishments!
Submit your news to Blake Belden at beldenba@vcu.edu or (804) 628-4578.
  Connect with us!
Join Massey's online communities.
Like us on Facebook
Follow us on Twitter
View our videos on YouTube